efineptakin alfa
neoimmunetech,genexine
['efineptakin', 'lymphoma']
armin ghobadi, md, presents a phase 1b study evaluating the safety, tolerability, and preliminary anti-tumor activity of nt-i7 (efineptakin alfa), in subjects w/ relapsed/refractory large b-cell lymphoma poster (#71) in mccormick, hall a, at 8am. #asco22 
A National Cancer Institute Comprehensive Cancer Center and member of the National Comprehensive Cancer Network